Intellia Therapeutics NTLA Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$96.23M-0.5% | -$95.79M+5.5% | -$101.32M-0.1% | -$101.26M+11.4% | -$114.33M+11.3% | ||
| $2.2M-7.5% | $2.38M-0.8% | $2.4M-4.0% | $2.5M+0.1% | $2.5M-2.7% | ||
| $13.48M-19.5% | $16.74M-14.6% | $19.6M-11.0% | $22.04M+0.9% | $21.84M-44.9% | ||
| -$117.35M-69.4% | -$69.29M+9.9% | -$76.9M+22.8% | -$99.62M+33.1% | -$148.93M-74.8% | ||
| $79K-37.3% | $126K+334% | $29K-87.9% | $239K-67.5% | $735K-25.1% | ||
| $66.31M+141% | $27.53M— | $0-100% | $106.91M+13.3% | $94.33M-37.8% | ||
| $33.57M+1,598% | $1.98M-98.3% | $114.86M+684% | $14.65M— | $0-100% | ||
| -$17.47M+56.1% | -$39.77M-207% | $37.22M— | —— | -$54.6M— | ||
| -$117.43M-69.2% | -$69.41M+9.8% | -$76.93M+23.0% | -$99.86M+33.3% | -$149.67M-73.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Intellia Therapeutics's cash flow data come from?
- Every line is extracted from Intellia Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.